WallStreetZenWallStreetZen

NASDAQ: SXTP
60 Degrees Pharmaceuticals Inc Stock Ownership - Who owns 60 Degrees Pharmaceuticals?

Insider buying vs selling

Have 60 Degrees Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Geoffrey S. DowPresident and CEO2024-01-3125,974$0.38
$9.74kBuy
Cheryl XuDirector2024-01-31200,000$0.38
$75.00kBuy
Knight Therapeutics IncInsider2023-07-2845,560$4.75
$216.18kBuy

1 of 1

SXTP insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SXTP insiders and whales buy or sell their stock.

SXTP Shareholders

What type of owners hold 60 Degrees Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Geoffrey S. Dow11.85%1,370,742$320.75kInsider
Knight Therapeutics Inc10.26%1,187,140$277.79kInsider
Kentucky Technology Inc4.54%525,000$122.85kInsider
Florida State University Research Foundation Inc3.50%405,000$94.77kInsider
Central Bank Trust Co3.09%357,000$83.54kInstitution
Walleye Capital LLC0.89%102,624$24.01kInstitution
Tyrone Miller0.88%101,928$23.85kInsider
Charles W. Allen0.09%10,000$2.34kInsider
Stephen Toovey0.09%10,000$2.34kInsider
Paul Field0.09%10,000$2.34kInsider

1 of 2

SXTP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SXTP4.00%31.34%Net BuyingNet Buying
WINT0.28%99.72%Net Buying
ONCO10.85%21.37%
CYTO0.52%0.00%
GOVX1.21%98.79%Net BuyingNet Buying

60 Degrees Pharmaceuticals Stock Ownership FAQ

Who owns 60 Degrees Pharmaceuticals?

60 Degrees Pharmaceuticals (NASDAQ: SXTP) is owned by 4.00% institutional shareholders, 31.34% 60 Degrees Pharmaceuticals insiders, and 64.66% retail investors. Geoffrey S. Dow is the largest individual 60 Degrees Pharmaceuticals shareholder, owning 1.37M shares representing 11.85% of the company. Geoffrey S. Dow's 60 Degrees Pharmaceuticals shares are currently valued at $326.24k.

If you're new to stock investing, here's how to buy 60 Degrees Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.